Source: Eur Respir J, 51 (2) 1702146; 10.1183/13993003.02146-2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Bartolome R. Celli, Nicholas Locantore, Ruth Tal-Singer, John Riley, Bruce Miller, Jørgen Vestbo, Julie C. Yates, Edwin K. Silverman, Caroline A. Owen, Miguel Divo, Victor Pinto-Plata, Emiel F.M. Wouters, Rosa Faner, Alvar Agusti. Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype. Eur Respir J, 51 (2) 1702146; 10.1183/13993003.02146-2017

Member's Comments

No comment yet.

Related content which might interest you: A multi-organ loss of tissue phenotype in COPD: involvement of the functional muscle–bone unit Source: Eur Respir J, 51 (6) 1800657; 10.1183/13993003.00657-2018 Year: 2018 Markers of fibrosis and tissue destruction in usual interstitial pneumonia associated with pulmonary emphysema Source: Eur Respir J 2007; 30: Suppl. 51, 489s Year: 2007 Respiratory function in systemic sclerosis patients Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015 T-cell pathways in lung tissue of patients with advanced COPD and IPF requiring lung transplantation Source: International Congress 2016 – Mechanisms of disease Year: 2016 Scleroderma lung disease: Detection of pulmonary hypertension using pulmonary function tests is problematic in patients with emphysema Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Metabolic phenotype and adipose tissue inflammation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Rituximab in severe, progressive interstitial lung disease Source: International Congress 2016 – Connective tissue disorders Year: 2016 Small airways diseases, excluding asthma and COPD: an overview Source: Eur Respir Rev 2013; 22: 131-147 Year: 2013 The decline in lung function is related to both emphysema and fibrosis extent in patients with idiopathic pulmonary fibrosis (IPF)/ combined pulmonary fibrosis and emphysema (CPFE) Source: International Congress 2014 – ILDs 1 Year: 2014 Pulmonary function involvement in scleroderma Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 An increased respiratory drive accounts for the severity of dyspnea in systemic sclerosis Source: Annual Congress 2013 –Respiratory muscles at rest and during exercise: from physiology to clinical context Year: 2013 Complex restrictive pulmonary function pattern in connective tissue disorders (CTD) with interstitial lung disease (ILD) Source: International Congress 2019 – Lung function testing: from experimental investigations to clinical applications Year: 2019 Possible role of liver disease and respiratory insufficiency in osteopenia in cystic fibrosis patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 ILD-India registry: Idiopathic pulmonary fibrosis (IPF) and connective tissue disease (CTD) associated interstitial lung disease (CTD-ILD) Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 The nature of inflammation and tissue damage in COPD Source: Annual Congress 2004 - Acquired somatic mutations in the pathogenesis of COPD Year: 2004 Interstitial lung disease Source: Eur Respir Rev 2013; 22: 26-32 Year: 2013 Pulmonary hypertension in interstitial lung disease Source: Eur Respir J 2008; 31: 1357-1367 Year: 2008 Remodelling of peripheral lung tissue in COPD Source: Eur Respir J 2008; 31: 913-914 Year: 2008 Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 The effect of pirfenidone on impaired lung function in patients with idiopathic pulmonary fibrosis (IPF) from Czech IPF registry Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016